Display Settings:

Format

Send to:

Choose Destination
    Clin Microbiol Rev. 2008 Jul;21(3):538-82.

    Acinetobacter baumannii: emergence of a successful pathogen.

    Source

    Division of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, 110 Francis Street, LMOB Suite GB, Boston, MA 02215, USA. apeleg@bidmc.harvard.edu

    Abstract

    Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Apart from its predilection for the seriously ill within intensive care units, A. baumannii has more recently caused a range of infectious syndromes in military personnel injured in the Iraq and Afghanistan conflicts. This review details the significant advances that have been made in our understanding of this remarkable organism over the last 10 years, including current taxonomy and species identification, issues with susceptibility testing, mechanisms of antibiotic resistance, global epidemiology, clinical impact of infection, host-pathogen interactions, and infection control and therapeutic considerations.

    PMID:
    18625687
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2493088
    Free PMC Article

    Images from this publication.See all images (2) Free text

    FIG. 2.
    FIG. 1.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk